AsahiKaseiBioprocess
@AKBioprocess
Followers
78
Following
0
Media
0
Statuses
308
AKB provides virus removal filters, chromatography products, and customizable skids for downstream processing of biological and plasma-derived products.
Glenview, IL
Joined January 2012
Promising Phase I trial of IPI-145, a small molecule PI3K inhibitor for lymphomas ( http://t.co/QYAArMgRgq)
http://t.co/xdOrFybm1L.
0
0
0
New Alzheimer's drug from Lundbeck expected to reach the market in 2017 (Reuters) http://t.co/Zwrcu12Ic8.
0
0
0
Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.
629
2K
9K
BioLineRx shares results for #peptide drug in Phase 2 trial for relapsed or refractory AML (Yahoo! Finance) http://t.co/a7lUqBGty0.
0
0
0
What were the major themes from the #biopharma industry in 2013? (FirstWord Pharma) http://t.co/Vwjn7pQHRW.
0
0
0
Pre-clinical cystic fibrosis candidate from Galapagos NV approaching Phase 1 trial (Wall St. Journal) http://t.co/gvMm4HScDy.
0
0
0
GlaxoSmithKline to invest approximately £200m to upgrade UK manufacturing plants (Manufacturing Chemist) http://t.co/F8HhLV8HzX.
0
0
0
Raptor Pharma files drug application to develop Procysbi for Leigh syndrome (San Francisco Business Times) http://t.co/qvnwV2hIyP.
0
0
0
Kamada completes Phase II/III clinical trial for inhaled Alpha-1 Antitrypsin (AAT) therapy (Business Wire) http://t.co/wyqkRotQBb.
0
0
0
First production run completed at ProMetic BioProduction Inc.'s plasma purification facility (Wall St. Journal) http://t.co/jILcB6cTqS.
0
0
0
CMC Biologics & University of Copenhagen to develop and manufacture placental malaria vaccine (BioSpectrum Asia) http://t.co/SCkdChcHOe.
0
0
0
As of July 2013, 340 drugs were in various stages of clinical trials in the state of MA (Boston Business Journal) http://t.co/G6y09MWcTQ.
0
0
0
Malvern, PA based VenatoRx Pharmaceuticals raises $3.4M to develop novel #antibiotics (Med City News) http://t.co/1gpmn9y1zO.
0
0
0
Iceland to help Alvotech build a 11,800 sq. meter facility to manufacture #biosimilars by 2016 (Reuters) http://t.co/uyx3UwEvgN.
0
0
0
Melior Pharmaceuticals I, Inc.and Bukwang Pharmaceutical Co. Ltd. to make insulin sensitizer (Business Wire) http://t.co/awmT2m7x4w.
0
0
0
Eye drop from Ohr Pharmaceutical may augment injection therapies for wet age-related macular degeneration (Reuters) http://t.co/NwPzwBL0kU.
0
0
0
Global #biosimilars market might be worth between $11 billion and $25 billion in 2020 (Firstpost) http://t.co/KniqcTF15Y.
0
0
0
Johnson & Johnson, Gilead, BMS, Merck and Abbvie fuel new wave of hepatitis C drugs (HCV Research and News) http://t.co/wQNjW0WyFV.
0
0
0
Celgene and Oncomed Pharmaceuticals to collaborate on up to six anti-cancer stem cell antibodies (Xconomy) http://t.co/5Y3cheCb1N.
0
0
0
10 key #pharma industry events to look forward to before the end of 2013 (FirstWord Pharma) http://t.co/AehKBg6V9C.
0
0
0
Safer alternative to Ambien? Possible blockbuster for insomnia manufactured by Merck (The New Yorker) http://t.co/ENKdshrpaD.
newyorker.com
Insomnia drugs like Ambien are notorious for their side effects. Has Merck created a blockbuster replacement?
0
0
0